These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8973654)

  • 1. Multiple solution conformations of the integrin-binding cyclic pentapeptide cyclo(-Ser-D-Leu-Asp-Val-Pro-). Analysis of the (phi, psi) space available to cyclic pentapeptides.
    Viles JH; Mitchell JB; Gough SL; Doyle PM; Harris CJ; Sadler PJ; Thornton JM
    Eur J Biochem; 1996 Dec; 242(2):352-62. PubMed ID: 8973654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution structure of a biologically active cyclic LDV peptide analogue containing a type II' beta-turn mimetic.
    Doyle PM; Harris JC; Moody CM; Sadler PJ; Sims M; Thornton JM; Uppenbrink J; Viles JH
    Int J Pept Protein Res; 1996 Jun; 47(6):427-36. PubMed ID: 8836770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined use of molecular dynamics simulations and NMR to explore peptide bond isomerization and multiple intramolecular hydrogen-bonding possibilities in a cyclic pentapeptide, cyclo(Gly-Pro-D-Phe-Gly-Val).
    Liu ZP; Gierasch LM
    Biopolymers; 1992 Dec; 32(12):1727-39. PubMed ID: 1472655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptide.
    Dutta AS; Crowther M; Gormley JJ; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Jamieson A; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
    J Pept Sci; 2000 Jul; 6(7):321-41. PubMed ID: 10946997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent cyclic peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-D-Arg-D-Arg) (ZD7349) compatible with depot formulation.
    Dutta AS; Gormley JJ; Coath M; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Ferguson R; Halterman T; Jamieson A; Moors JA; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
    J Pept Sci; 2000 Aug; 6(8):398-412. PubMed ID: 10969869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mimicry of beta II'-turns of proteins in cyclic pentapeptides with one and without D-amino acids.
    Weisshoff H; Präsang C; Henklein P; Frömmel C; Zschunke A; Mügge C
    Eur J Biochem; 1999 Feb; 259(3):776-88. PubMed ID: 10092864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of potent and selective alpha(4)beta(7) integrin antagonists.
    Boer J; Gottschling D; Schuster A; Semmrich M; Holzmann B; Kessler H
    J Med Chem; 2001 Aug; 44(16):2586-92. PubMed ID: 11472212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and conformational analysis of cyclic pentapeptide endothelin antagonists.
    Lin M; Chan MF; Balaji VN; Castillo RS; Larive CK
    Int J Pept Protein Res; 1996 Sep; 48(3):229-39. PubMed ID: 8897090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A conformational study by 1H NMR of a cyclic pentapeptide antagonist of endothelin.
    Coles M; Sowemimo V; Scanlon D; Munro SL; Craik DJ
    J Med Chem; 1993 Sep; 36(18):2658-65. PubMed ID: 8410978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural recognition of an ICAM-1 peptide by its receptor on the surface of T cells: conformational studies of cyclo (1, 12)-Pen-Pro-Arg-Gly-Gly-Ser-Val-Leu-Val-Thr-Gly-Cys-OH.
    Gürsoy RN; Jois DS; Siahaan TJ
    J Pept Res; 1999 Apr; 53(4):422-31. PubMed ID: 10406220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformations of heterochiral and homochiral proline-pseudoproline segments in peptides: context dependent cis-trans peptide bond isomerization.
    ; Raghothama S; Raghavender US; Aravinda S; Shamala N; Balaram P
    Biopolymers; 2009; 92(5):405-16. PubMed ID: 19373926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution conformation of a cyclic pentapeptide endothelin antagonist. Comparison of structures obtained from constrained dynamics and conformational search.
    Krystek SR; Bassolino DA; Bruccoleri RE; Hunt JT; Porubcan MA; Wandler CF; Andersen NH
    FEBS Lett; 1992 Mar; 299(3):255-61. PubMed ID: 1544503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solvent effects on the conformation of cyclo(-D-Trp-D-Asp-Pro-D-Val-Leu-). An NMR spectroscopy and molecular modeling study.
    Gonnella NC; Zhang X; Jin Y; Prakash O; Paris CG; Kolossváry I; Guida WC; Bohacek RS; Vlattas I; Sytwu T
    Int J Pept Protein Res; 1994 May; 43(5):454-62. PubMed ID: 8070969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Backbone modifications in cyclic peptides. Conformational analysis of a cyclic pseudopentapeptide containing a thiomethylene ether amide bond replacement.
    Anwer MK; Sherman DB; Spatola AF
    Int J Pept Protein Res; 1990 Oct; 36(4):392-9. PubMed ID: 2079394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution conformations of two flexible cyclic pentapeptides: cyclo(Gly-Pro-D-Phe-Gly-Ala) and cyclo(Gly-Pro-D-Phe-Gly-Val).
    Stroup AN; Rockwell AL; Gierasch LM
    Biopolymers; 1992 Dec; 32(12):1713-25. PubMed ID: 1472654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of cyclic peptides: the crystal and solution conformation of cyclo(Phe-Phe-Aib-Leu-Pro).
    Zanotti G; Saviano M; Saviano G; Tancredi T; Rossi F; Pedone C; Benedetti E
    J Pept Res; 1998 Jun; 51(6):460-6. PubMed ID: 9650721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The design and synthesis of potent cyclic peptide VCAM-VLA-4 antagonists incorporating an achiral Asp-Pro mimetic.
    Fotouhi N; Joshi P; Fry D; Cook C; Tilley JW; Kaplan G; Hanglow A; Rowan K; Schwinge V; Wolitzky B
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1171-3. PubMed ID: 10866374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent alpha 4 beta 1 peptide antagonists as potential anti-inflammatory agents.
    Jackson DY; Quan C; Artis DR; Rawson T; Blackburn B; Struble M; Fitzgerald G; Chan K; Mullins S; Burnier JP; Fairbrother WJ; Clark K; Berisini M; Chui H; Renz M; Jones S; Fong S
    J Med Chem; 1997 Oct; 40(21):3359-68. PubMed ID: 9341911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational analysis of cyclic hexapeptides designed as constrained ligands for the SH2 domain of the p85 subunit of phosphatidylinositol-3-OH kinase.
    Barchi JJ; Nomizu M; Otaka A; Roller PP; Burke TR
    Biopolymers; 1996 Feb; 38(2):191-208. PubMed ID: 8589253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The conformation of cyclo(-D-Pro-Ala4-) as a model for cyclic pentapeptides of the DL4 type.
    Heller M; Sukopp M; Tsomaia N; John M; Mierke DF; Reif B; Kessler H
    J Am Chem Soc; 2006 Oct; 128(42):13806-14. PubMed ID: 17044709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.